N-[3-[5-[(1S)-1-hydroxyethyl]-1,3,4-oxadiazol-2-yl]cyclobutyl]-5-(3-methylphenyl)-1,2-oxazole-3-carboxamide
C19H20N4O4 — CID 126677297
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[3-[5-[(1S)-1-hydroxyethyl]-1,3,4-oxadiazol-2-yl]cyclobutyl]-5-(3-methylphenyl)-1,2-oxazole-3-carboxamide
N-[3-[5-[(1S)-1-hydroxyethyl]-1,3,4-oxadiazol-2-yl]cyclobutyl]-5-(3-methylphenyl)-1,2-oxazole-3-carboxamide (PubChem CID 126677297) has the molecular formula C19H20N4O4 and a molecular weight of 368.39 g/mol. Its IUPAC name is N-[3-[5-[(1S)-1-hydroxyethyl]-1,3,4-oxadiazol-2-yl]cyclobutyl]-5-(3-methylphenyl)-1,2-oxazole-3-carboxamide.
Molecular Properties
| Compound Name | N-[3-[5-[(1S)-1-hydroxyethyl]-1,3,4-oxadiazol-2-yl]cyclobutyl]-5-(3-methylphenyl)-1,2-oxazole-3-carboxamide |
|---|---|
| PubChem CID | 126677297 |
| Molecular Formula | C19H20N4O4 |
| Molecular Weight | 368.39 g/mol |
| Exact Mass | 368.15 |
| IUPAC Name | N-[3-[5-[(1S)-1-hydroxyethyl]-1,3,4-oxadiazol-2-yl]cyclobutyl]-5-(3-methylphenyl)-1,2-oxazole-3-carboxamide |
| SMILES | Cc1cccc(-c2cc(C(=O)NC3CC(c4nnc([C@H](C)O)o4)C3)no2)c1 |
| InChI | InChI=1S/C19H20N4O4/c1-10-4-3-5-12(6-10)16-9-15(23-27-16)17(25)20-14-7-13(8-14)19-22-21-18(26-19)11(2)24/h3-6,9,11,13-14,24H,7-8H2,1-2H3,(H,20,25)/t11-,13?,14?/m0/s1 |
| InChIKey | FNUWEVAQJNAWBC-XGNXJENSSA-N |
| XLogP | 2.76 |
| TPSA | 114.28 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 27 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 368.39 |
| LogP ≤ 5 | 2.76 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 126677297 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.